|
Beurs gesloten -
Andere beurzen
|
Voorbeurs 08:42:50 | |||
| 0,5410 EUR | +1,88% |
|
0,5440 | +0,55% |
| 13/07 | AB Science staakt drie klinische studies met masitinib | MT |
| 10/07 | AB Science rationaliseert portefeuille en focust op twee moleculen |  |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1,88% | +5,87% | -29,47% | -48,77% | -64,78% | -62,11% | -84,41% | -96,04% | -96,01% | 49,8 mln. | |
| +0,32% | -0,66% | +0,49% | +16,08% | +23,69% | +64,21% | +23,18% | +70,91% | +123,21% | 322 mld. | |
| +0,21% | +2,87% | -2,95% | +30,08% | +16,76% | +33,60% | -10,00% | -18,08% | +45,33% | 71,6 mld. | |
| -0,91% | +0,74% | +3,89% | +29,05% | +22,64% | +39,85% | +92,63% | +103,55% | +722,93% | 9,79 mld. | |
| -1,86% | -5,79% | -5,88% | +4,74% | -0,79% | -2,24% | -7,83% | -28,58% | +47,47% | 8,39 mld. | |
| +1,80% | -1,99% | -8,78% | -20,92% | -36,60% | -15,78% | -13,19% | -36,29% | - | 4,3 mld. | |
| -0,68% | -1,87% | +4,85% | -19,76% | -34,61% | -34,78% | +6,01% | +37,23% | +80,39% | 3,81 mld. | |
| +3,08% | -1,41% | -14,43% | +10,70% | +23,15% | -12,94% | +15,81% | -35,76% | - | 3,58 mld. | |
| -2,15% | -3,40% | -7,12% | -6,73% | -10,20% | +25,70% | +41,55% | +66,90% | +100,49% | 2,59 mld. | |
| +0,85% | +9,88% | +0,90% | -11,31% | -12,37% | -0,25% | -3,21% | +71,92% | - | 2,25 mld. | |
| -.--% | +4,37% | -0,11% | -7,82% | -12,48% | -22,39% | -14,67% | -5,56% | -39,97% | 1,76 mld. | |
| +1,97% | -6,17% | -6,70% | -15,52% | -9,45% | -29,35% | +19,46% | -32,74% | - | 1,74 mld. | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1,64 mld. | |
| -5,32% | +8,99% | +23,79% | +60,62% | +174,51% | +228,52% | +1.540,28% | +708,71% | - | 1,27 mld. | |
| +15,69% | +9,46% | -2,80% | -32,73% | -34,52% | +59,89% | +50,70% | +29,67% | +488,04% | 1,26 mld. | |
| +1,59% | -2,26% | -17,78% | -34,40% | -22,74% | -53,23% | -30,21% | - | - | 1,1 mld. | |
| -5,88% | -10,58% | -6,11% | -11,81% | -17,31% | -13,50% | +12,59% | +64,53% | +61,15% | 1,06 mld. | |
| +2,91% | -10,88% | -35,24% | -15,43% | -1,94% | -17,79% | +63,13% | -13,70% | - | 982 mln. | |
| +1,77% | +7,11% | +1,77% | -17,94% | -20,94% | -36,23% | -73,87% | -82,72% | - | 913 mln. | |
| +0,41% | +0,62% | -1,41% | -12,37% | -12,05% | -42,20% | -9,78% | -47,31% | -65,66% | 866 mln. | |
| Gemiddelde | +0,83% | -0,53% | -5,42% | -5,49% | -1,58% | +5,74% | +85,17% | +42,04% | +133,40% | 22,03 mld. | |
| Gewogen gemiddelde per kap. | +0,34% | -0,13% | -0,45% | +16,82% | +20,13% | +53,22% | +22,09% | +53,18% | +121,72% |
Kies jouw editie
Alle financiële informatie op nationaal niveau
